Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
US Army

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,027,859

« Back to Dashboard

Summary for Patent: 7,027,859

Title:Electrotransport delivery device having improved safety and reduced abuse potential
Abstract:An electrotransport device (20) for delivering one or more therapeutic agents through the skin includes electrodes (30,32) for contacting the skin (34), at least one electrode containing the agent, a power source (22) for generating electrical current (I.sub.L) for delivering the agent, a current generating and controlling means (24), and a disabling means (26) for permanently and irreversibly disabling the current. The disabling means (26) may include a timer means (66), a counter means (82), or a body parameter sensor (134) and limit comparator (132) to effect permanent disabling. The disabling means may be a permanent transition to a disabled logic state, a permanent discharge of a power supply source (22), or a permanent diversion of electrotransport current from the electrodes (30,32), or a combination of the above. The permanent disabling means may include a circuit connection means (304,308,326,328) having a frangible conducting member (332) which permanently fractures and causes an irreversible open circuit in the connection to the electrodes (334,342) upon removing a disposable/single use electrode assembly (300) from a reusable portion of an electrotransport device.
Inventor(s): McNichols; Larry A. (Coon Rapids, MN), Badzinski; John D. (Coon Rapids, MN), Reining; William N. (Cross Plains, WI), Lattin; Gary A. (Forest Lake, MN), Haak; Ronald P (Menlo Park, CA), Phipps; Joseph B. (Plymouth, MN)
Assignee: ALZA Corporation (Mountain View, CA)
Application Number:08/312,336
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;

No matches for this query

International Patent Family for Patent: 7,027,859

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria173942► Subscribe
Australia3594095► Subscribe
Canada2195657► Subscribe
Germany69506426► Subscribe
Denmark0781152► Subscribe
European Patent Office0781152► Subscribe
Spain2125660► Subscribe
Japan2008220985► Subscribe
Japan4165659► Subscribe
Japan4322304► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Federal Trade Commission
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus